a clear trendp=0.051
In the subgroup of patients that came from LAMA or LABA monotherapy, blood eosinophil count showed a clear trend (p=0.051) of comparative effectiveness based on the number of SABA inhalers used in favor of extrafine BDP/FF with increasing eosinophil count.